Li Xiaohai

Dr. Li Xiaohai


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
LXLi Xiaohai
Li Xiaohai
LXLihua Xu
Lihua Xu
SPShengdong Pan
Shengdong Pan
AWAihong Wang
Aihong Wang
XXXinwu Xu
Xinwu Xu
DZDandan Zhang
Dandan Zhang
Benzene is an established leukemogen increasingly linked to cardiovascular injury, but whether low-level exposure depletes the circulating progenitor cells that maintain vascular repair is unknown. We studied 202 workers from 12 benzene-related enterprises in Ningbo, China (May–October 2022), quantifying six urinary benzene, toluene, and xylene metabolites and enumerating CD31+ cells, CD34+ cells, and CD34+CD31+CD45+ circulating progenitor cells (CPCs) by ISHAGE-consistent flow cytometry. Two hypotheses were prespecified with Holm–Bonferroni control: urinary trans,trans-muconic acid (tt-MA) would be inversely associated with CD34+ cells and CPCs. Per doubling of tt-MA, CD34+ cells were 11.8% lower (95% CI: −21.7 to −0.6; q = 0.045) and CPCs were 5.1% lower (−9.3 to −0.8; q = 0.045) after covariate adjustment. The tt-MA–CD34+ association persisted among never-smokers (−14.0%; 95% CI: −26.0 to −0.2), deficits were concentrated in the highest tt-MA quartile (CD34+: −45.6%; P-trend = 0.042), and no toluene- or xylene-derived metabolite was associated with any outcome. Low-level benzene exposure is associated with benzene-specific depletion of circulating vascular-repair progenitor cells, a candidate early mechanism of cardiovascular injury that warrants longitudinal evaluation.